Form 13-F position report

BIOMX INC

Reported by Barclays PLC

PHGE CUSIP 09090D301 Manager CIK 0000312069

Reported 0 shares, down 25,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 84025
2024-09-30 0
2024-09-30 25500
2024-12-31 18253
2025-03-31 13893
2025-06-30 11250
2025-09-30 13125
2025-12-31 0
2025-12-31 2461
2026-03-31 4940
2026-06-30 458
2026-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for BIOMX INC held by Barclays PLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 0 -1,316 (-100.0%) 0 $0 2026-11-06
Q2 2026 Unchanged 1,316 0 (0.0%) < 0.01% $458 2026-08-14
Q1 2026 Unchanged 1,316 0 (0.0%) < 0.01% $4,940 2026-05-15
Q4 2025 New 1,316 +1,316 (0.0%) < 0.01% $2,461 2026-02-13
Q4 2025 Reduced 0 -25,000 (-100.0%) 0 $0 2026-02-13
Q3 2025 Unchanged 25,000 0 (0.0%) < 0.01% $13,125 2025-11-12
Q2 2025 Unchanged 25,000 0 (0.0%) < 0.01% $11,250 2025-08-13
Q1 2025 Unchanged 25,000 0 (0.0%) < 0.01% $13,893 2025-05-15
Q4 2024 Unchanged 25,000 0 (0.0%) < 0.01% $18,253 2025-02-13
Q3 2024 New 25,000 +25,000 (0.0%) < 0.01% $25,500 2024-11-15
Q3 2024 Reduced 0 -250,000 (-100.0%) 0 $0 2024-11-15
Q2 2024 New 250,000 +250,000 (0.0%) < 0.01% $84,025 2024-08-14

Who else reported the position

16 managers reported BIOMX INC for Q4 2025.

Managers reporting BIOMX INC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Barclays PLC This report Reduced 0 -25,000 0 $0 6 qtrs
JPMorgan Chase & Co Reduced 0 -430,000 0 $0 5 qtrs
ADAR1 Capital Management LLC Reduced 0 -77,656 0 $0 6 qtrs
SBI Securities Co Ltd Reduced 0 -400 0 $0 5 qtrs
Alyeska Investment Group L P Reduced 0 -1,590,738 0 $0 5 qtrs
TWO SIGMA INVESTMENTS LP Reduced 0 -19,125 0 $0 2 qtrs
Ikarian Capital LLC Reduced 0 -392,976 0 $0 6 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Reduced 0 -2,494,108 0 $0 6 qtrs
DAFNA Capital Management LLC Reduced 0 -401,136 0 $0 6 qtrs
TWO SIGMA SECURITIES LLC Reduced 0 -10,568 0 $0 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.